What is Expressable?
Founded in late 2020 and headquartered in Austin, TX, Expressable is an online speech therapy practice dedicated to expanding access to quality services. The company, established in 2019, leverages technology to deliver comprehensive speech and language pathology services remotely, addressing a critical need for accessible and convenient healthcare solutions. Expressable's business model is designed to overcome geographical barriers and provide support to a wider patient population, positioning it as a key player in the rapidly evolving telehealth landscape.
How much funding has Expressable raised?
Expressable has raised a total of $45.5M across 3 funding rounds:
Angel/Seed
$4.5M
Series A
$15M
Series B
$26M
Angel/Seed (2021): $4.5M with participation from Lerer Hippeau Ventures, NextView Ventures, and AmplifyHer Ventures
Series A (2022): $15M led by F-Prime Capital Partners, Lerer Hippeau Ventures, NextView Ventures, and Amplifyher Ventures
Series B (2024): $26M supported by HarbourVest, F-Prime Capital Partners, and Digitalis Ventures
Key Investors in Expressable
HarbourVest
HarbourVest Partners is a global private markets investment solutions provider, offering fund investing, secondary, and direct co-investments. They are headquartered in Boston, Massachusetts.
F-Prime Capital Partners
F-Prime Capital Partners, established in 2002, is a venture capital firm focused on investing in healthcare and technology companies, leveraging a team of investors, engineers, doctors, and scientists. They are located in Massachusetts.
Digitalis Ventures
Digitalis Ventures engineers solutions for unmet health needs by investing in biotechnology and technology-enabled solutions aimed at improving health outcomes and reducing costs. Their multidisciplinary team focuses on financing, building, and scaling enterprises.
What's next for Expressable?
With its recent Series B financing, Expressable is poised for accelerated expansion and service enhancement. The substantial capital injection is expected to fuel strategic initiatives, including technology development, market penetration, and the scaling of its clinical team. This investment signals a strong belief in Expressable's potential to disrupt the traditional speech therapy market and solidify its position as a leader in digital health. The company's focus on accessibility and quality care, combined with this significant backing, suggests a future of sustained growth and innovation in serving individuals requiring speech and language support.
See full Expressable company page
